ADAMS BRIAN (Chief Legal Officer) sold 11.3% of their position (6.37K shares) of KYMERA THERAPEUTICS, INC. on the open market
Open‑market sale worth $744.3K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 9/4/2026ACC: 0001193125-26-383874
Officer· Chief Legal Officer
Since Mar 2026
-6.37K
Net shares
Net seller
$744.3K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
6.37K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−1.21K
Price / share
$115.55
Trade value
$139.70K
% of position
2.1%
9/4/2026
56.63K→55.42K
Common Stock
Direct
Shares
−3.02K
Price / share
$116.81
Trade value
$353.35K
% of position
5.5%
9/4/2026
55.42K→52.39K
Common Stock
Direct
Shares
−2.14K
Price / share
$117.57
Trade value
$251.25K
% of position
4.1%
9/4/2026
52.39K→50.25K
Total
Net shares
−6.37K
Net value
-$744.30K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/4/2026 | S · Sale | −1.21K | $115.55 | $139.70K | 2.1% | 56.63K | 55.42K |
| Common Stock Direct | 9/4/2026 | S · Sale | −3.02K | $116.81 | $353.35K | 5.5% | 55.42K | 52.39K |
| Common Stock Direct | 9/4/2026 | S · Sale | −2.14K | $117.57 | $251.25K | 4.1% | 52.39K | 50.25K |
| Total | −6.37K | -$744.30K | ||||||
Derivative Transactions0
No derivative transactions reported